Wednesday, February 10, 2010, 1:47PM AEST - The Australian Stockmarket closes in 2 hours and 18 minutes.
To create a watchlist or portfolio of shares, Register

Corcept Therapeutics Inc. (CORT)

7:42AM AEST: 2.64 USD  Up 0.06 (2.29%)  
 MORE ON CORT 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Corcept Therapeutics Incorporat (NCM:CORT) Delayed quote dataEdit
Last Trade:2.64 USD
Trade Time: 7:42AM AEST
Change:Up 0.06 (2.29%)
Prev Close:2.58
Open:2.61
Bid:1.91 x 1000
Ask:2.98 x 200
1y Target Est:4.50
Day's Range:2.57 - 2.64
52wk Range:0.73 - 3.22
Volume:15,098
Avg Vol (3m):31,858.7
Market Cap:164.93M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add CORT to Portfolio   Download Data

 HEADLINES 
CORCEPT THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 9)
CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit
EDGAR Online (Fri, Jan 8)
Corcept Therapeutics upgraded by Ladenburg Thalmann
Briefing.com (Thu, Jan 7)
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Marketwire (Wed, Jan 6)
CORCEPT THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
EDGAR Online (Fri, Nov 13)
New Star Analyst Rankings for Corcept Therapeutics Incorporat
StarMine (Thu, Nov 12)
Corcept Therapeutics Announces Recent Highlights and Third Quarter 2009 Financial Results
Marketwire (Wed, Nov 11)
CORCEPT THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
EDGAR Online (Thu, Oct 15)
Corcept Therapeutics: Pump Up the Volume
at TheStreet.com (Wed, Oct 14)
Corcept Therapeutics Announces Pricing of Private Placement Cash Sufficient to Fund Company Through Corlux NDA Submission
Marketwire (Wed, Oct 14)
More Headlines for CORT...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.41
EPS Est (in 2 years) (Dec-10) :-0.39
Avg Rec (current)*:1.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the development of drugs for the treatment of severe metabolic and psychiatric disorders.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices